Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens

키워드

참고문헌 (94)

1. Salyers AA, "Revenge of the microbes: how bacterial resistance is undermining the antibiotic miracle. Washington" (2005), ASM Press
2. Brötz-Oesterhelt H, "Postgenomic strategies in antibacterial drug discovery", Future Microbiol, 5, pp.1553~1579 (2010)
3. Woodford N, "Infections caused by Gram-positive bacteria: a review of the global challenge", J Infect, 59(Suppl 1), pp.S4~S16 (2009)
4. Kumarasamy KK, "Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study", Lancet Infect Dis, 10, pp.597~602 (2010)
5. Marchaim D, "Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age", Eur J Clin Microbiol Infect Dis, 27, pp.1045~1051 (2008)
6. Ho J, "Multiresistant Gram-negative infections: a global perspective", Curr Opin Infect Dis, 23, pp.546~553 (2010)
7. Maragakis LL, "Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options", Clin Infect Dis, 46, pp.1254~1263 (2008)
8. Bergogne-Bérézin E, "Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features", Clin Microbiol Rev, 9, pp.148~165 (1996)
9. Munoz-Price LS, "Acinetobacter infection", N Engl J Med, 358, pp.1271~1281 (2008)
10. Peleg AY, "Acinetobacter baumannii: emergence of a successful pathogen", Clin Microbiol Rev, 21, pp.538~582 (2008)
11. Jean SS, "High burden of antimicrobial resistance in Asia", Int J Antimicrob Agents, 37, pp.291~295 (2011)
12. Nemec A, "Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU)", Res Microbiol, 162, pp.393~404 (2011)
13. Bouvet PJ, "Identification and biotyping of clinical isolates of Acinetobacter", Ann Inst Pasteur Microbiol, 138, pp.569~578 (1987)
14. Dortet L, "Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens", J Clin Microbiol, 44, pp.4471~4478 (2006)
15. Lee Y, "Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 66(1), pp.66~72 (2011), OXFORD UNIV PRESS
16. Wendt C, "Survival of Acinetobacter baumannii on dry surfaces", J Clin Microbiol, 35, pp.1394~1397 (1997)
17. Jawad A, "Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates", J Clin Microbiol, 36, pp.1938~1941 (1998)
18. Getchell-White SI, "The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus", Infect Control Hosp Epidemiol, 10, pp.402~407 (1989)
19. Petersen K, "Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center", J Clin Microbiol, 49, pp.159~166 (2011)
20. Hidron AI, "NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007", Infect Control Hosp Epidemiol, 29, pp.996~1011 (2008)
21. Kyungwon Lee, "Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009", Yonsei Medical Journal, 52(5), pp.793~802 (2011), 연세대학교의과대학
22. Wu CJ, "Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003", J Microbiol Immunol Infect, 39, pp.135~143 (2006)
23. Song JY, "Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections", JOURNAL OF MEDICAL MICROBIOLOGY, 60(5), pp.605~611 (2011), SOC GENERAL MICROBIOLOGY
24. Kim JW, "Characterization of Acinetobacter baumannii carrying blaOXA-23, blaPER-1 and armA in a Korean hospital", Clin Microbiol Infect, 14, pp.716~718 (2008)
25. Styers D, "Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States", Ann Clin Microbiol Antimicrob, 5, pp.2~ (2006)
26. Knothe H, "Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens", Infection, 11, pp.315~317 (1983)
27. Paterson DL, "Extended-spectrum β-lactamases: a clinical update", Clin Microbiol Rev, 18, pp.657~686 (2005)
28. Bauernfeind A, "Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins", Infection, 17, pp.316~321 (1989)
29. Kim J, "Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea", J Clin Microbiol, 36, pp.1446~1449 (1998)
30. Yigit H, "Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae", Antimicrob Agents Chemother, 45, pp.1151~1161 (2001)
31. Yong D, "Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India", Antimicrobial Agents And Chemotherapy, 53(12), pp.5046~5054 (2009)
32. Peleg AY, "Hospital-acquired infections due to gram-negative bacteria", N Engl J Med, 362, pp.1804~1813 (2010)
33. Vila J, "Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii", J Antimicrob Chemother, 59, pp.1210~1215 (2007)
34. Hujer KM, "Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: defining a unique family of class C enzymes", Antimicrob Agents Chemother, 49, pp.2941~2948 (2005)
35. Corvec S, "AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains", J Antimicrob Chemother, 52, pp.629~635 (2003)
36. Lin YC, "Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan", Antimicrob Agents Chemother, 54, pp.2078~2084 (2010)
37. Lee Y, "A Novel Insertion Sequence, ISAba10, Inserted into ISAba1 Adjacent to the bla(OXA-23) Gene and Disrupting the Outer Membrane Protein Gene carO in Acinetobacter baumannii", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 55(1), pp.361~363 (2011), AMER SOC MICROBIOLOGY
38. Fournier PE, "Comparative genomics of multidrug resistance in Acinetobacter baumannii", PLoS Genet, 2, pp.e7~ (2006)
39. Falagas ME, "The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa", J Med Microbiol, 55, pp.1619~1629 (2006)
40. Paterson DL, "step closer to extreme drug resistance (XDR) in gram-negative bacilli", Clin Infect Dis, 45, pp.1179~1181 (2007)
41. Mera RM, "Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States", Microb Drug Resist, 16, pp.209~215 (2010)
42. 이경원, "Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007", Yonsei Medical Journal, 51(6), pp.901~911 (2010), 연세대학교의과대학
43. Poirel L, "Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital", J Clin Microbiol, 41, pp.3542~3547 (2003)
44. Nordmann P, "Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa", Antimicrob Agents Chemother, 37, pp.962~969 (1993)
45. Yong D, "High prevalence of PER-1 extended-spectrum β-lactamase-producing Acinetobacter spp. in Korea", Antimicrob Agents Chemother, 47, pp.1749~1751 (2003)
46. Bush K, "Updated functional classification of β-lactamases", Antimicrob Agents Chemother, 54, pp.969~976 (2010)
47. Lee K, "blaVIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital", Antimicrob Agents Chemother, 46, pp.1053~1058 (2002)
48. Yum JH, "Molecular characterization of metallo-β-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettes", J Antimicrob Chemother, 49, pp.837~840 (2002)
49. Lee K, "Novel acquired metallo-β-lactamase gene, bla", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 49(11), pp.4485~4491 (2005)
50. 성지연, "IMP-1과 OXA -lactamase를 생성하는 Carbapenem 내성 Acinetobacter baumanni 의 확산", Annals of Laboratory Medicine, 28(1), pp.16~23 (2008), 대한진단검사의학회
51. Lim YM, "Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates", JOURNAL OF CLINICAL MICROBIOLOGY, 45(3), pp.902~905 (2007), AMER SOC MICROBIOLOGY
52. Lee JH, "Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 59, pp.633~639 (2007), OXFORD UNIV PRESS
53. Lee K, "Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea", International Journal Of Antimicrobial Agents, 33(6), pp.520~524 (2009)
54. Brown S, "OXA β-lactamases in Acinetobacter: the story so far", J Antimicrob Chemother, 57, pp.1~3 (2006)
55. Jeon BC, "Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea", JOURNAL OF CLINICAL MICROBIOLOGY, 43(5), pp.2241~2245 (2005)
56. Hee Young Yang, "Outbreaks of Imipenem Resistant Acinetobacter Baumannii Producing OXA-23 β-Lactamase in a Tertiary Care Hospital in Korea", Yonsei Medical Journal, 50(6), pp.764~770 (2009), 연세대학교의과대학
57. Lee K, "Korean Nationwide Surveillance of Antimicrobial Resistance Group. VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals", Emerg Infect Dis, 9, pp.868~871 (2003)
58. Kim CK, "Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182", Diagnostic Microbiology And Infectious Disease, 68(4), pp.432~438 (2010), Elsevier BV
59. Higgins PG, "OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii", Antimicrob Agents Chemother, 53, pp.5035~5038 (2009)
60. Lin MF, "Emergence and dissemination of blaOXA-23-carrying imipenem-resistant Acinetobacter sp in a regional hospital in Taiwan", J Microbiol Immunol Infect, 44, pp.39~44 (2011)
61. Mendes RE, "Emergence and widespread dissemination of OXA-23, -24", 40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program, 2009, pp.63, 55~59
62. Shaw KJ, "Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes", Microbiol Rev, 57, pp.138~163 (1993)
63. Hujer KM, "Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center", Antimicrob Agents Chemother, 50, pp.4114~4123 (2006)
64. Lee H, "Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 56, pp.305~312 (2006)
65. Hooper DC, "Mechanisms of fluoroquinolone resistance", Drug Resist Updat, 2, pp.38~55 (1999)
66. Karlowsky JA, "Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network", Int J Antimicrob Agents, 19, pp.21~31 (2002)
67. 구선회, "Genetic Basis of Multidrug-resistant Acinetobacter baumannii Clinical Isolates from Three University Hospitals in Chungcheong Province, Korea", Annals of Laboratory Medicine, 30(5), pp.498~506 (2010), 대한진단검사의학회
68. Martínez-Martínez L, "Quinolone resistance from a transferable plasmid", Lancet, 351, pp.797~799 (1998)
69. Touati A, "First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals", Diagn Microbiol Infect Dis, 60, pp.287~290 (2008)
70. Strahilevitz J, "Plasmid-mediated quinolone resistance: a multifaceted threat", Clin Microbiol Rev, 22, pp.664~689 (2009)
71. Wang YF, "In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008", Diagn Microbiol Infect Dis, 68, pp.73~79 (2010)
72. Damier-Piolle L, "AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii", Antimicrob Agents Chemother, 52, pp.557~562 (2008)
73. Song JY, "In vitro activities of carbapenem", sulbactam combination, colistin, colistin, J Antimicrob Chemother, pp.2007, 60[DOI]
74. Park YK, "In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea", Int J Antimicrob Agents, 33, pp.289~290 (2009)
75. Arroyo LA, "In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group", Antimicrob Agents Chemother, 53, pp.1295~1296 (2009)
76. Peleg AY, "Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report", J Antimicrob Chemother, 59, pp.128~131 (2007)
77. 이경원, "2006년 서울과 경기지역 4개 병원에서 분리된 Carbapenem 내성 Acinetobacter spp.의 내성 기전과 분자역학", 대한임상미생물학회지, 13(1), pp.27~33 (2010), 대한임상미생물학회
78. Ko KS, "High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 60(5), pp.1163~1167 (2007), OXFORD UNIV PRESS
79. Adams MD, "Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system", Antimicrob Agents Chemother, 53, pp.3628~3634 (2009)
80. Moffatt JH, "Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production", Antimicrob Agents Chemother, 54, pp.4971~4977 (2010)
81. Sykes R, "The 2009 Garrod lecture: the evolution of antimicrobial resistance: a Darwinian perspective", J Antimicrob Chemother, 65, pp.1842~1852 (2010)
82. Talbot GH, "The antibiotic development pipeline for multidrug-resistant gram-negative bacilli: current and future landscapes", Infect Control Hosp Epidemiol, 31(Suppl 1), pp.S55~S58 (2010)
83. MacDougall C, "Antimicrobial stewardship programs in health care systems", Clin Microbiol Rev, 18, pp.638~656 (2005)
84. Fishman N, "Antimicrobial stewardship", Am J Med, 119, pp.S53~S61 (2006)
85. Livermore DM, "Bacterial resistance: origins, epidemiology, and impact", Clin Infect Dis, 36, pp.S11~S23 (2003)
86. 김의종, "전국병원감염감시체계 중환자실 부문 결과 보고: 2008년 7월부터 2009년 6월까지 1년간의 결과와 3년간 전국 중환자실 병원감염발생률의 분석", 병원감염관리, 15(1), pp.14~25 (2010), 대한병원감염관리학회
87. Lu PL, "Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase", J Antimicrob Chemother, 63, pp.641~647 (2009)
88. Peterson LR, "To screen or not to screen for methicillin-resistant Staphylococcus aureus", J Clin Microbiol, 48, pp.683~689 (2010)
89. Carlet J, "The “zero risk” concept for hospital-acquired infections: a risky business!", Clin Infect Dis, 49, pp.747~749 (2009)
90. Yuji K, "Police investigation into multidrug-resistant Acinetobacter baumannii outbreak in Japan", Clin Infect Dis, 52, pp.422~ (2011)
91. 송재훈, "지역사회획득 폐렴의 치료지침 권고안", Tuberculosis and Respiratory Diseases, 67(4), pp.281~302 (2009), 대한결핵및호흡기학회
92. 장선미, "Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians", Health Policy and Planning, 20(5), pp.302~309
93. Metlay JP, "Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients", J Gen Intern Med, 17, pp.87~94 (2002)
94. Liew YX, "Inappropriate carbapenem use in Singapore public hospitals: opportunities for antimicrobial stewardship", Int J Antimicrob Agents, 37, pp.87~88 (2011)

관련 논문AI추천